Elsevier

Environment International

Volume 99, February 2017, Pages 131-150
Environment International

Review article
Measuring biomarkers in wastewater as a new source of epidemiological information: Current state and future perspectives

https://doi.org/10.1016/j.envint.2016.12.016Get rights and content

Highlights

  • Wastewater biomarkers provide information on lifestyle habits, health and wellbeing.

  • Specific criteria should be followed to select a suitable biomarker.

  • Report of the current knowledge of the most relevant biomarkers used so far

  • Proposal of potential wastewater biomarkers for future applications

  • Review of pharmacokinetic data and stability in urine and wastewater for each biomarker

Abstract

The information obtained from the chemical analysis of specific human excretion products (biomarkers) in urban wastewater can be used to estimate the exposure or consumption of the population under investigation to a defined substance. A proper biomarker can provide relevant information about lifestyle habits, health and wellbeing, but its selection is not an easy task as it should fulfil several specific requirements in order to be successfully employed. This paper aims to summarize the current knowledge related to the most relevant biomarkers used so far. In addition, some potential wastewater biomarkers that could be used for future applications were evaluated. For this purpose, representative chemical classes have been chosen and grouped in four main categories: (i) those that provide estimates of lifestyle factors and substance use, (ii) those used to estimate the exposure to toxicants present in the environment and food, (iii) those that have the potential to provide information about public health and illness and (iv) those used to estimate the population size. To facilitate the evaluation of the eligibility of a compound as a biomarker, information, when available, on stability in urine and wastewater and pharmacokinetic data (i.e. metabolism and urinary excretion profile) has been reviewed. Finally, several needs and recommendations for future research are proposed.

Introduction

Relevant epidemiological information about lifestyle habits, public health and wellbeing can be obtained from the chemical analysis of urban wastewater. This approach, called wastewater-based epidemiology (WBE), is based on the analysis of specific human metabolic excretion products (biomarkers) in wastewater as indicators of consumption or exposure of the population served by the sewer network under investigation to different substances. WBE has been successfully applied as a suitable approach for the estimation of illicit drugs consumption (Ort et al., 2014, Thomaidis et al., 2016, Thomas et al., 2012, van Nuijs et al., 2011a, Zuccato et al., 2008), but it has also recently been employed to assess other lifestyle-related factors such as alcohol (Rodríguez-Álvarez et al., 2015, Ryu et al., 2016), nicotine (Castiglioni et al., 2015b, Lopes et al., 2014, Rodríguez-Álvarez et al., 2014b), caffeine (Senta et al., 2015a) and new psychoactive substances (NPS) (Kinyua et al., 2015, Reid et al., 2014a, van Nuijs et al., 2014). WBE has also been applied to verify community-wide exposure to endocrine disruptors and antimicrobial agents in personal care and household products (O'Brien et al., 2015, Rydevik et al., 2015). The broad range of information that can be gathered from wastewater opens up the possibility of expanding WBE to other human biomarkers providing clues about diet, health, diseases and exposure to contaminants. For example by linking exposure to environmental or food contaminants with health outcomes such as diabetes or cancer.

In general, a human biomarker can be an endogenous compound (produced naturally in the body) or a metabolite of a xenobiotic/exogenous substance (produced through metabolic processes after intentional consumption of a substance, accidental exposure to environmental contaminants, as well as through diet or ingestion of a substance). Biomarkers can be classified on the basis of their function as biomarkers of exposure (compounds that give information about substances consumed or ingested) and biomarkers of effect (indicators of measurable changes or alterations in an organism that can be associated with health problems or wellbeing) and on the basis of biological nature (e.g. metabolites, hormones), or of the disease they can indicate (e.g. cardiovascular biomarkers, obesity biomarkers) (Pischon, 2009).

The selection of a specific biomarker is not an easy task, as it needs to satisfy different criteria (Fig. 1) (Castiglioni and Gracia-Lor, 2015, Gracia-Lor et al., 2016). From a WBE perspective, a suitable biomarker must be excreted mainly via urine and concentration levels in urine should be at least in the μg/L range to ensure its detection in raw wastewater after dilution (Chen et al., 2014).

A biomarker should also be sufficiently stable in wastewater during the transport (in-sewer stability) from the input (i.e. toilet) to the sampling point and during sampling, storage and analysis (in-sample stability) (McCall et al., 2016a). In wastewater biomarkers can undergo further transformation due to microbial activity (Mardal and Meyer, 2014) and/or sorption to particulate matter (Baker and Kasprzyk-Hordern, 2011, Daughton, 2012a, McCall et al., 2016a). The fate of biomarkers in the sewer can be also predicted by using mathematical models to simulate physicochemical and microbial processes (Bisceglia and Lippa, 2014, McCall et al., 2016b, Ramin et al., 2016). It is important to note that biomarker transformation pathways in the sewer might be different from human metabolic pathways.

Furthermore, a biomarker should preferably be specific to the compound under investigation and unique to human metabolism, thus ensuring that its presence only derives from human excretion and not from exogenous sources (Daughton, 2012b). Therefore, pharmacokinetic data on human metabolism are necessary but unfortunately this information is not always feasible as for many substances it is very limited or do not even exist. This information, however, is highly relevant not only to back-calculate the consumption/exposure of/to a certain substance by a community, but also to distinguish the amount of a substance originating from human metabolism or other sources. Unfortunately, pharmacokinetic studies are time-consuming and have to fulfil strict ethical rules. Alternative approaches, which allow for the identification and selection of appropriate biomarkers, are therefore required; for example, in-vitro studies using liver enzymes, which metabolize the parent compound, help in the elucidation of the chemical structure of the metabolites formed (i.e. possible biomarkers) formed (Mardal et al., 2016). Computer-based in-silico modelling also allows the prediction of pharmacokinetics (Reid et al., 2014a). However these alternatives provide qualitative information on metabolism, but not data regarding excretion rates of parent substances and their metabolites (Gracia-Lor et al., 2016).

The present manuscript emerges within the framework of the pan-European inter-disciplinary network (Sewage analysis CORE group-SCORE), which brings together experts from different disciplines interested in standardizing the WBE approach and in coordinating international studies (http://score-cost.eu/). The aim of this review is to describe the criteria for selecting suitable biomarkers and to give an overview of relevant human (urinary) metabolites and potential wastewater biomarkers. Biomarkers have been grouped in four sections: (i) those that provide estimates of lifestyle factors and substance use, (ii) those used to estimate the exposure to toxicants present in the environment and food, (iii) those giving information about public health and (iv) those used to estimate the population size. For each group and biomarker, a thorough review of the available pharmacokinetic data (i.e. metabolism and excretion profile) and stability in urine and wastewater (if known) is provided. This information can be used to evaluate their suitability according to the criteria described above. Finally, potential gaps or limitations are discussed and future research directions are proposed.

Section snippets

Lifestyle and substance use biomarkers

Initially, WBE was applied to evaluate lifestyle, in particular illicit drug use within a community. Its ability to deliver objective and near-real-time data on drug use, being able to detect changes over time and local patterns of use, suggests that this method can be used as a complementary and extended data source to existing epidemiological tools. WBE has been well established for monitoring the use of cocaine, cannabis, amphetamine, methamphetamine and MDMA

Exposure biomarkers from environment and food

Two important exposure pathways for potentially harmful compounds are the dietary intake and the exposure from the surrounding daily environment. The monitoring of various classes of compounds for which exposure commonly occurs through these routes is necessary to safeguard public health. Representative chemical classes have been chosen as examples for this paper. Pesticides, mycotoxins and parabens are three classes of compounds for which exposure occurs through the intake of contaminated food

Health biomarkers

Community health programs play an essential role for public health agencies to monitor and evaluate the present status of health in a community and measure the success of programs aimed at improving it. Current challenges mainly consist of the quick and reliable evaluation of the overall health of a population, and detect possible health and illness threats such as pandemics or higher prevalence of diabetes or cancer.

The quantitative measurement of specific exogenous and endogenous biomarkers

Population biomarkers

Accurate estimation of population size is necessary to normalize WBE data to the per capita level, which allows for temporal and spatial comparisons to be made (van Nuijs et al., 2011b). A review of all uncertainties associated with WBE found that there is a direct relationship between the uncertainty in measuring the population size and the uncertainty in the calculated daily loads of drugs (Castiglioni et al., 2013, Lai et al., 2015a). Therefore, accurate data on population size are needed to

Conclusions and future perspectives

WBE is a rapidly developing scientific discipline with a strong transdisciplinary character. It has shown great progress, and opens up many possibilities for expanding its application to provide relevant information about lifestyle and public health.

This review has outlined potential wastewater biomarkers of exposure or effect that could be used for future applications associated with lifestyle and wellbeing studies. However, it has also discussed limitations and highlighted that more research

Acknowledgements

This work was supported by the COST Action ES1307 “SCORE – Sewage biomarker analysis for community health assessment”. Emma Gracia-Lor is very grateful to Generalitat Valenciana, Conselleria d'Educació, Investigació, Cultura i Esport (APOSTD/2015, Programa VALi + d) for her post-doctoral contract. Lubertus Bijlsma acknowledges NPS-Euronet (HOME/2014/JDRUG/AG/DRUG/7086), co-funded by the European Union, for his post-doctoral fellowship. Erika Castrignanò, Richard Bade, Juliet Kinyua, Pedram Ramin,

References (311)

  • D. Błędzka et al.

    Parabens. From environmental studies to human health

    Environ. Int.

    (2014)
  • T. Boogaerts et al.

    Spatial and temporal trends in alcohol consumption in Belgian cities: a wastewater-based approach

    Drug Alcohol Depend.

    (2016)
  • V.L. Borova et al.

    Multi-residue determination of 10 selected new psychoactive substances in wastewater samples by liquid chromatography–tandem mass spectrometry

    Talanta

    (2015)
  • J.M. Brausch et al.

    A review of personal care products in the aquatic environment: environmental concentrations and toxicity

    Chemosphere

    (2011)
  • I.D. Bull et al.

    The origin of faeces by means of biomarker detection

    Environ. Int.

    (2002)
  • D. Butler et al.

    Characterising the quantity and quality of domestic wastewater inflows

    Water Sci. Technol.

    (1995)
  • S. Castiglioni et al.

    Identification of cocaine and its metabolites in urban wastewater and comparison with the human excretion profile in urine

    Water Res.

    (2011)
  • E. Castrignanò et al.

    Enantiomeric profiling of chiral drug biomarkers in wastewater with the usage of chiral liquid chromatography coupled with tandem mass spectrometry

    J. Chromatogr. A

    (2016)
  • C. Chen et al.

    Increases in use of novel synthetic stimulant are not directly linked to decreased use of 3,4-methylenedioxy-N-methylamphetamine (MDMA)

    Forensic Sci. Int.

    (2013)
  • C. Chen et al.

    Towards finding a population biomarker for wastewater epidemiology studies

    Sci. Total Environ.

    (2014)
  • M. Colomer-Lluch et al.

    Antibiotic resistance genes in bacterial and bacteriophage fractions of Tunisian and Spanish wastewaters as markers to compare the antibiotic resistance patterns in each population

    Environ. Int.

    (2014)
  • C. Coscollà et al.

    Occurrence of currently used pesticides in ambient air of Centre Region (France)

    Atmos. Environ.

    (2010)
  • F. Curtin et al.

    Day-to-day intraindividual reliability and interindividual differences in monoamines excretion

    J. Affect. Disord.

    (1996)
  • C.G. Daughton

    Real-time estimation of small-area populations with human biomarkers in sewage

    Sci. Total Environ.

    (2012)
  • C.G. Daughton

    Using biomarkers in sewage to monitor community-wide human health: Isoprostanes as conceptual prototype

    Sci. Total Environ.

    (2012)
  • D. De Boer et al.

    Piperazine-like compounds: a new group of designer drugs-of-abuse on the European market

    Forensic Sci. Int.

    (2001)
  • S. Dresen et al.

    Forensic confirmatory analysis of ethyl sulfate – a new marker for alcohol consumption – by liquid-chromatography/electrospray ionization/tandem mass spectrometry

    J. Am. Soc. Mass Spectrom.

    (2004)
  • E. Emke et al.

    Enantiomer profiling of high loads of amphetamine and MDMA in communal sewage: a Dutch perspective

    Sci. Total Environ.

    (2014)
  • W.E. Fantegrossi et al.

    Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ9-THC: mechanism underlying greater toxicity?

    Life Sci.

    (2014)
  • H. Fromme et al.

    Overall internal exposure to mycotoxins and their occurrence in occupational and residential settings — an overview

    Int. J. Hyg. Environ. Health

    (2016)
  • H. Fromme et al.

    Non-phthalate plasticizers in German daycare centers and human biomonitoring of DINCH metabolites in children attending the centers (LUPE 3)

    Int. J. Hyg. Environ. Health

    (2016)
  • P. Gago-Ferrero et al.

    Occurrence of multiclass UV filters in treated sewage sludge from wastewater treatment plants

    Chemosphere

    (2011)
  • D.W. Gao et al.

    Phthalate esters in the environment: a critical review of their occurrence, biodegradation, and removal during wastewater treatment processes

    Sci. Total Environ.

    (2016)
  • I. González-Mariño et al.

    Determination of drugs of abuse in water by solid-phase extraction, derivatisation and gas chromatography-ion trap-tandem mass spectrometry

    J. Chromatogr. A

    (2010)
  • E. Gracia-Lor et al.

    Multi-class determination of personal care products and pharmaceuticals in environmental and wastewater samples by ultra-high performance liquid-chromatography-tandem mass spectrometry

    Talanta

    (2012)
  • E. Gracia-Lor et al.

    Occurrence and removal of pharmaceuticals in wastewater treatment plants at the Spanish Mediterranean area of Valencia

    Chemosphere

    (2012)
  • E. Gracia-Lor et al.

    Refining correction factors for back-calculation of illicit drug use

    Sci. Total Environ.

    (2016)
  • A. Asimakopoulos et al.

    Neuropsychiatric pharmaceuticals and illicit drugs in wastewater treatment plants: a review

    Environ. Chem.

    (2016)
  • R.C. Baselt

    Disposition of Toxic Drugs and Chemicals in Man

    (2004)
  • J.A. Baz-Lomba et al.

    Comparison of pharmaceutical, illicit drug, alcohol, nicotine and caffeine levels in wastewater with sale, seizure and consumption data for 8 European cities

    BMC Public Health

    (2016)
  • F. Been et al.

    Population normalization with ammonium in wastewater-based epidemiology: application to illicit drug monitoring

    Environ. Sci. Technol.

    (2014)
  • S. Bencharit et al.

    Structural basis of heroin and cocaine metabolism by a promiscuous human drug-processing enzyme

    Nat. Struct. Biol.

    (2003)
  • N.L. Benowitz et al.

    Metabolism of nicotine to cotinine studied by a dual stable isotope method

    Clin. Pharmacol. Ther.

    (1994)
  • V.S. Bhat et al.

    Derivation of an oral reference dose (RfD) for the nonphthalate alternative plasticizer 1,2-cyclohexane dicarboxylic acid, di-isononyl ester (DINCH)

    J. Toxicol. Environ. Health B Crit. Rev.

    (2014)
  • L. Bijlsma et al.

    Improvements in analytical methodology for the determination of frequently consumed illicit drugs in urban wastewater

    Anal. Bioanal. Chem.

    (2014)
  • L. Bijlsma et al.

    Identification and characterization of a novel cathinone derivative 1-(2,3-dihydro-1H-inden-5-yl)-2-phenyl-2-(pyrrolidin-1-yl)-ethanone seized by customs in Jersey

    Forensic Toxicol.

    (2016)
  • K.J. Bisceglia et al.

    Stability of cocaine and its metabolites in municipal wastewater — the case for using metabolite consolidation to monitor cocaine utilization

    Environ. Sci. Pollut. Res.

    (2014)
  • J. Blanchard et al.

    Comparison of the urinary metabolite profile of caffeine in young and elderly males

    Br. J. Clin. Pharmacol.

    (1985)
  • V.L. Borova et al.

    Highly sensitive determination of 68 psychoactive pharmaceuticals, illicit drugs, and related human metabolites in wastewater by liquid chromatography-tandem mass spectrometry

    Anal. Bioanal. Chem.

    (2014)
  • A.J. Brewer et al.

    Normalized diurnal and between-day trends in illicit and legal drug loads that account for changes in the population

    Environ. Sci. Technol.

    (2012)
  • Cited by (205)

    View all citing articles on Scopus
    View full text